FTCM
XLRN

First Trust Capital Management’s Acceleron Pharma XLRN Stock Holding History

First Trust Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-34,350
Closed -$5.91M – 306
2021
Q3 		$5.91M Buy
+34,350
New +$4.49M 0.9% 18

First Trust Capital Management's XLRN Position: Q4 2021 in Review

First Trust Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 34,350 shares — an estimated $5.91M sold.

First Trust Capital Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $5.91M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • First Trust Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • First Trust Capital Management sold 34,350 Acceleron Pharma shares in Q4 2021, an estimated $5.91M.
  • First Trust Capital Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • First Trust Capital Management's Acceleron Pharma position peaked at $5.91M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on First Trust Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.